P
Study Title: Comparison of Serum Fibrinogen-Albumin Ratio Among Children with Autoimmune and Infectious Encephalitis Aged 1–14 Years
Authors: Kodamana H, Panda P, Sharawat I, Elwadhi A, Gupta D, Palayullakandi A, Tiwari L
Institution: All India Institute of Medical Sciences, Rishikesh
Background
Pediatric encephalitis (infectious or autoimmune) is heterogeneous and carries risk of severe neurological outcomes.
Early biomarkers for diagnosis and prognosis are limited.
Fibrinogen: pro-inflammatory protein, elevated in CNS disease
Albumin: reflects nutritional status and better prognosis
Fibrinogen/Albumin Ratio Percentage (FARP) may serve as a diagnostic and prognostic marker.
Objectives
Compare serum FARP in children (1–14 years) with infectious encephalitis (IE) vs autoimmune encephalitis (AE)
Evaluate prognostic value of FARP for functional outcomes
Methods
Participants: 50 children (1–14 years) with clinically and radiologically confirmed/probable AE or IE
Measurement:
FARP = (Fibrinogen / Albumin) × 100, measured within 6 hours
Outcomes:
PCPC (Pediatric Cerebral Performance Category) for all cases
CASE (Clinical Assessment Scale in Autoimmune Encephalitis) for AE cases
Outcomes classified as:
Favorable: PCPC 1–3
Poor: PCPC ≥4
Analysis: t-tests, non-parametric tests, multivariate analysis (p < 0.05 significant)
Results
Demographics:
AE patients younger: 6.3 vs 9.1 years (p < 0.001)
Fewer males in AE: 8/21 vs 20/29 (p < 0.001)
Longer illness duration in AE: 11 vs 3 days (p < 0.001)
Clinical features: IE had higher rates of:
Seizures, fever, vomiting, headache, neuropsychiatric & extrapyramidal features (all p < 0.001)
FARP levels:
IE: 8.9 ± 4.1
AE: 6.2 ± 3.4 (p < 0.001)
Association with outcomes:
Poor outcome groups had higher FARP:
AE: 7.1 vs 5.9 (p = 0.02)
IE: 9.1 vs 8.0 (p = 0.03)
Conclusion
FARP is higher in infectious encephalitis than autoimmune encephalitis in children.
Elevated FARP is associated with poor functional outcomes in both AE and IE.
FARP may serve as a useful early diagnostic and prognostic biomarker in pediatric encephalitis.
No comments:
Post a Comment